Aqemia Announces Pilot Study With Janssen to Utilize Aqemia’s Physics-driven Drug Discovery Technology

Image by andreas160578 from Pixabay   PRESS RELEASE — February 14, 2022, 08:00 AM Eastern Standard Time ANTWERP, Belgium and PARIS — (BUSINESS WIRE) — Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum-inspired physics, announces it has entered into a pilot study agreement with Janssen. Through the agreement, Aqemia’s unique technology to predict the potency of small molecules for a […]Read More